Recombinant adenovirus snake venom cystatin inhibits the growth, invasion, and metastasis of B16F10 cells in vitro and in vivo

Melanoma Research

Volumn 23, Issue 6, 2013, Pages 444-451

  Xie, Qun ^a,b   Tang, Nanhong ^a   Lin, Yangyuan ^b   Wang, Xiaoqian ^a   Lin, Xu ^a   Lin, Jianyin ^a  

^a FUJIAN MEDICAL UNIVERSITY   (China)

^b PUTIAN UNIVERSITY   (China)

Author keywords

adenovirus; cystatin; gene therapy; invasion; melanoma; metastasis; snake venom

Indexed keywords

CYSTATIN; RECOMBINANT ADENOVIRUS SNAKE VENOM CYSTATIN; SNAKE VENOM; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CANCER GROWTH; CONTROLLED STUDY; GENE EXPRESSION; IN VITRO STUDY; IN VIVO STUDY; LUNG WEIGHT; MALE; METASTASIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; TRANSGENE; TUMOR CELL; TUMOR INVASION;

ADENOVIRIDAE; ANIMALS; CELL MOVEMENT; CELL PROLIFERATION; COLLAGEN; CYSTATINS; DRUG COMBINATIONS; GENETIC THERAPY; LAMININ; MALE; MELANOMA, EXPERIMENTAL; MICE; MICE, INBRED C57BL; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; NEOPLASM TRANSPLANTATION; PROTEOGLYCANS; RECOMBINANT PROTEINS; SNAKE VENOMS; TRANSFECTION;

EID: 84887619001     PISSN: 09608931     EISSN: 14735636     Source Type: Journal    
DOI: 10.1097/CMR.0000000000000031     Document Type: Article

References (36)

1. Sharma A, Tandon M, Bangari DS, Mittal SK. Adenoviral vector-based strategies for cancer therapy. Curr Drug Ther 2009; 4:117-138
2. Rabha S, Sharma B, Labhasetwar V. Inhibition of tumor angiogenesis and growth by nanoparticle-mediated p53 gene therapy in mice. Cancer Gene Ther 2012; 19:530-537
3. Li W, Li DM, Chen K, Chen Z, Zong Y, Yin H, et al. Development of a gene therapy strategy to target hepatocellular carcinoma based inhibition of protein phosphatase 2A using the alpha-fetoprotein promoter enhancer and pgk promoter: an in vitro and in vivo study. BMC Cancer 2012; 12:547
4. Blaese RM, Culver KW, Miller AD, Carter CS, Fleisher T, Clerici M, et al. T lymphocyte-directed gene therapy for ADA-SCID: initial trial results after 4 years. Science 1995; 270:475-480
5. Rein DT, Breidenbach M, Curiel DT. Current developments in adenovirusbased cancer gene therapy. Future Oncol 2006; 2:137-143
6. Briggs JJ, Hargen MH, Johansen HT, Riker AI, Abrahamson M, Fodstad \O, et al. Cystatin E/M suppresses legumain activity and invasion of human melanoma. BMC Cancer 2010; 10:17
7. Wegiel B, Jiborn T, Abrahamson M, Helczynski L, Otterbein L, Persson JL, et al. Cystatin C is downregulated in prostate cancer and modulates invasion of prostate cancer cells via MAPK/Erk and androgen receptor pathways. PLoS One 2009; 4:e7953
8. Kopitz C, Anton M, Gansbacher B, Kruger A. Reduction of experimental human fibrosarcoma lung metastasis in mice by adenovirus-mediated cystatin C expression in the host. Cancer Res 2005; 65:8608-8612
9. Cox JL. Cystatins and cancer. Front Biosci 2009; 14:463-474
10. Evans HJ, Barrett AJ. A cystatin-like cysteine proteinase inhibitor from venom of the African puff adder (Bitis arietans). Biochem J 1987; 246:795-797
11. Ritonja A, Evans HJ, Machleidt W, Barrett AJ. Amino acid sequence of a cystatin from venom of the African puff adder (Bitis arietans). Biochem J 1987; 246:799-802
12. Brillard-bourdet M, Nguyen V, Ferrer-di martino M, Gauthier F, Moreau T. Purification and characterization of a new cystatin inhibitor from Taiwan cobra (Naja naja atra) venom. Biochem J 1998; 331:239-244
13. Sloane BF, Yan S, Podgorski I, Linebaugh BE, Cher ML, Mai J, et al. Cathepsin B and tumor proteolysis: contribution of the tumor microenvironment. Semin Cancer Biol 2005; 15:149-157
14. Song J,Wan R,Weng SM, Lin X, Lin JY. Gene synthesis of cystatin from snake venom and its expression in E. coil. J Fujian Med Univ 2004; 38:241-245
15. Xie Q, Tang N, Wan R, Qi Y, Lin X, Lin JY. Recombinant snake venom cystatin inhibits the growth, invasion and metastasis of B16F10 cells and MHCC97H cells in vitro and in vivo. Toxicon 2011; 57:704-711
16. Wan R, Zheng HY, Song J, Lin X, Lin JY. The studies on effect of snake venom cystatin for invasion and metastasis of the human gastric carcinoma cell line. Chinese J Clin Oncol 2005; 32:961-965
17. Wan R, Zheng HY, Song J, Weng SM, Lin X, Lin JY. The effect of cysteine protease inhibitor of snake venom (sv-cystatin) on mouse melanoma cells invasion in vitro and in vivo. Acta Anat Sin 2006; 37:640-645
18. Tang N, Xie Q,Wang X, Li X, Chen Y, Lin X, et al. Inhibition of invasion and metastasis of MHCC97H cells by expression of snake venom cystatin through reduction of proteinases activity and epithelial-mesenchymal transition. Arch Pharm Res 2011; 34:781-789
19. O'neill AM, Smith AN, Spangler EA, Whitley EM, Schleis SE, Bird RC. Resistance of canine lymphoma cells to adenoviral infection due to reduced cell surface RGD binding integrins. Cancer Biol Ther 2011; 11:651-658
20. Kobayashi H, Fukuda Y, Yoshida R, Kanada Y, Nishiyama S, Suzuki M, et al. Suppressing effects of dietary supplementation of soybean trypsin inhibitor on spontaneous, experimental and peritoneal disseminated metastasis in mouse model. Int J Cancer 2004; 10:519-524
21. Crissman JD, Hatfield J, Schaldenbrand M, Sloane BF, Honn KV. Arrest and extravasation of B16 amelanotic melanoma in murine lungs. A light and electron microscopic study. Lab Invest 1985; 53:470-478
22. Abrahamson M, Alvarez-fernandez M, Nathanson CM. Cystatins. Biochem Soc Symp 2003; 70:179-199
23. Colbert JD, Plechanovova A, Watts C. Glycosylation directs targeting and activation of cystatin from intracellular and extracellular sources. Traffic 2009; 10:425-437
24. Pavlova A, Krupa JC, Mort JS, Abrahamson M, Bjork I. Cystatin inhibition of cathepsin B requires dislocation of the proteinase occluding loop. Demonstration by release of loop anchoring through mutation of his110. FEBS Lett 2000; 487:156-160
25. Ekstrom U, Wallin H, Lorenzo J, Holmqvist B, Abrahamson M, Avile s FX. Internalization of cystatin C in human cell lines. FEBS J 2008; 275: 4571-4582
26. Wallin H, Bjarnadottir M, Vogel LK,Wasse lius J, Ekstrom U, Abrahamson M. Cystatins - extra- and intracellular cysteine protease inhibitors: high-level secretion and uptake of cystatin C in human neuroblastoma cells. Biochimie 2010; 92:1625-1634
27. Arnberg N. Adenovirus receptors: implications for targeting of viral vectors. Trends Pharmacol Sci 2012; 33:442-448
28. Smith JG, Wiethoff CM, Stewart PL, Nemerow GR. Adenovirus. Curr Top Microbiol Immunol 2010; 343:195-224
29. Sharma A, Li X, Bangari DS, Mittal SK. Adenovirus receptors and their implications in gene delivery. Virus Res 2009; 143:184-194
30. Keppler D. Towards novel anti-cancer strategies based on cystatin function. Cancer Lett 2006; 235:159-176
31. Xie Q,Wan R, Lin X, Lin JY. Effects of snake venom cystatin gene on gene expression profiles in mouse melanoma cell line B16F1. Ai Zheng 2008; 27:716-722
32. Qi YL, Ji MK, Xie Q, Huang QL, Lin JY. Effect of snake venom cystatin gene on the protein expression profiles of mouse melanoma B16F1 cells. Chin Pharmacol Bull 2011; 27:791-797
33. Boissan M, De Wever O, Lizarraga F,Wendum D, Poincloux R, Chignard N, et al. Implication of metastasis suppressor NM23-H1 in maintaining adherens junctions and limiting the invasive potential of human cancer cells. Cancer Res 2010; 70:7710-7722
34. Moissoglu K, McRoberts KS, Meier JA, Theodorescu D, Schwartz MA. Rho GDP dissociation inhibitor 2 suppresses metastasis via unconventional regulation of RhoGTPases. Cancer Res 2009; 69:2838-2844
35. Eguchi T, Inoue T, Fujii K, Yamaguchi H, Nishiyama K, Yonemasu H, et al. Laminin-5 (gamma2 chain) is a marker of invading cancer cells in human gallbladder carcinoma: special emphasis on extension of carcinoma in situ along Rokitansky-Aschoff sinuses. Oncol Rep 2008; 20:33-39
36. Xie Q, Tang N,Wan R, Qi Y, Lin X, Lin J. Recombinant snake venom cystatin inhibits tumor angiogenesis in vitro and in vivo associated with downregulation of VEGF-A165, Flt-1 and bFGF. Anticancer Agents Med Chem 2013; 13:663-671.